Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-03-02 @ 4:12 AM
Study NCT ID:
NCT06531018
Status:
RECRUITING
Last Update Posted:
2025-02-18
First Post:
2024-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
Sponsor:
Renata PLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
55603092023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None